Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

0.5971
Delayed Data
As of May 27
 +0.0271 / +4.75%
Today’s Change
0.53
Today|||52-Week Range
8.75
-80.68%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close0.57
Today’s open0.64
Day’s range0.57 - 0.66
Volume192,362
Average volume (3 months)159,733
Market cap$15.6M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+66.37%
Earnings growth (this year)+33.19%
Earnings growth (next 5 years)--
Revenue growth (last year)+17,425.00%
P/E ratioNM
Price/Sales100.27
Price/Book0.40

Competitors

 Today’s
change
Today’s
% change
BLPHBellerophon Therapeu...-0.03-2.52%
ACSTAcasti Pharma Inc+0.01+0.67%
CYCCCyclacel Pharmaceuti...-0.03-6.69%
GNVCGenVec Inc-0.05-7.28%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$701.0K
Annual profit (last year)-$52.2M
Net profit margin-7,444.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Independent Director
Scott M. Rocklage
President &
Chief Operating Officer
Michael Wyand
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers

Search for Jobs